EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische Studie

Neoadjuvant chemotherapy followed by transoral robotic surgery versus upfront surgery for locoregionally advanced oropharyngeal carcinoma: A propensity score matched analysis

Claudio Sampieri iD, Eleonora Cioccoloni, Andrea Costantino iD, Dahee Kim, Kyuin Lee, Giuseppe Meccariello, Giovanni Cammaroto, Claudio Vicini, Se-Heon Kim iD

Head & Neck · 2025

DOI: 10.1002/hed.27904 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Head & Neck, 2025. Verfasst von Claudio Sampieri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Functional Unit of Head and Neck Tumors, Hospital Clínic, Barcelona, Spain. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Robotic Surgical Procedures, Neoadjuvant Therapy, Propensity Score. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transoral robotic surgery (TORS) performed after neoadjuvant chemotherapy (NAC) is a promising treatment for advanced‐stage oropharyngeal carcinoma (OPSCC) able to reduce the adjuvant therapy administration rate.

Methods

A retrospective bi‐centric study was conducted to analyze NAC + TORS versus upfront TORS patients. A 1:1 propensity score matching was used to compare the two groups.

Results

Among the 300 patients with stage III‐IV OPSCC, 204 patients were matched for comparing NAC + TORS versus upfront TORS. Between the two groups, no significant difference was observed in recurrences and in survival for RFS, OS, and DSS. In the NAC + TORS p16‐positive population, adjuvant therapy could be spared in 51% versus 16% in the upfront surgery cohort ( p < 0.001) due to the lower frequency of pathological risk factors after NAC.

Conclusions

NAC followed by TORS for locoregionally advanced OPSCC demonstrated to achieve non‐inferior survival outcomes to upfront surgery, while in the p16‐positive population allowed to significantly spare adjuvant therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oropharyngeal NeoplasmsRobotic Surgical ProceduresNeoadjuvant TherapyPropensity ScoreHumansMaleFemaleMiddle AgedRetrospective StudiesAgedChemotherapy, AdjuvantNeoplasm StagingAdultTreatment OutcomeCarcinoma, Squamous Cell

Stichwörter der Autor:innen

TORS: deintensificationde‐escalationhead and neck cancerinductionneoadjuvantoropharynx

Autor:innen und Institutionen

  • Functional Unit of Head and Neck Tumors, Hospital Clínic, Barcelona, Spain.
  • Department of Otorhinolaryngology, Hospital Clínic, Barcelona, Spain.
  • Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
  • Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, South Korea.
  • Unit of Otolaryngology, Head-Neck and Oral Surgery, Department of Head-Neck Surgery, Morgagni Pierantoni Hospital, Forlì, Italy.
  • Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.

ORCID-Profile: Claudio Sampieri, Andrea Costantino, Se-Heon Kim

Zitieren

APA

Sampieri, C., Cioccoloni, E., Costantino, A., Kim, D., Lee, K., Meccariello, G., Cammaroto, G., Vicini, C., & Kim, S. H. (2025). Neoadjuvant chemotherapy followed by transoral robotic surgery versus upfront surgery for locoregionally advanced oropharyngeal carcinoma: A propensity score matched analysis. Head & Neck. https://doi.org/10.1002/hed.27904

Vancouver

Sampieri C, Cioccoloni E, Costantino A, Kim D, Lee K, Meccariello G, et al. Neoadjuvant chemotherapy followed by transoral robotic surgery versus upfront surgery for locoregionally advanced oropharyngeal carcinoma: A propensity score matched analysis. Head & Neck. 2025. doi:10.1002/hed.27904

BibTeX
@article{Sampieri2025,
  author = {Sampieri, Claudio and Cioccoloni, Eleonora and Costantino, Andrea and Kim, Dahee and Lee, Kyuin and Meccariello, Giuseppe and Cammaroto, Giovanni and Vicini, Claudio and Kim, Se-Heon},
  title = {Neoadjuvant chemotherapy followed by transoral robotic surgery versus upfront surgery for locoregionally advanced oropharyngeal carcinoma: A propensity score matched analysis},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.27904}
}
Kostenlos starten →